Sustained growth-promoting effects of vosoritide in children with achondroplasia from an ongoing phase 3 extension study.
Savarirayan R, Irving M, Wilcox WR, Bacino CA, Hoover-Fong JE, Harmatz P, Polgreen LE, Palm K, Prada CE, Kubota T, Arundel P, Kotani Y, Leiva-Gea A, Bober MB, Hecht JT, Legare JM, Lawrinson S, Low A, Sabir I, Huntsman-Labed A, Day JRS.
Savarirayan R, et al. Among authors: kotani y.
Med. 2024 Dec 30:100566. doi: 10.1016/j.medj.2024.11.019. Online ahead of print.
Med. 2024.
PMID: 39740666